Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing

NCT04904510 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04904510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04904510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Completed
Start date
November 20, 2020
Completion date
March 9, 2021
Enrollment
297 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19